FDA 483 - Novacyl (Thailand) Ltd.

Novacyl (Thailand) Ltd., a manufacturer, was inspected by the FDA, revealing significant deficiencies in its Quality Unit's handling of complaint investigations. The firm failed to extend investigations to potentially affected batches and did not complete complaint investigation forms within required timelines, indicating a lapse in quality management. These issues suggest a need for improved adherence to internal procedures and comprehensive quality oversight.